PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hospital Nacional de Parapléjicos, FENNSI Group, SESCAM, Toledo, Spain.\', \'Instituto Cajal-CSIC, Spanish Research Council/Consejo Superior de Investigaciones Científicas-CSIC, Madrid, Spain.\', \'Istituti Clinici Scientifici Maugeri IRCCS, Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors, Pavia, Italy.\', \'Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/1073858420939033
?:doi
?:hasPublicationType
?:journal
  • The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
is ?:pmid of
?:pmid
?:pmid
  • 32659199
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all